Eye diseases

Bevacizumab as effective as aflibercept for central retinal vein occlusion

Off-label drug is as effective as standard treatment for macular oedema, according to randomised controlled trial.

Retinal image showing macular oedema

Source: Shutterstock.com

Researchers have demonstrated the efficacy of bevacizumab for treating macular oedema secondary to central retinal vein occlusion.

Bevacizumab is frequently used off-label for treating macular oedema resulting from central retinal vein occlusion (CRVO), despite a lack of supporting data.

In a study published in JAMA[1] (online, 9 May 2017), researchers carried out a randomised trial to establish whether the drug is non-inferior to aflibercept, a licensed treatment for CRVO with a similar mode of action. After six months of injections every four weeks, the mean change in visual acuity letter score increased by 18.6 in the bevacizumab group (n=182) and by 18.9 in the aflibercept group (n=180), a difference between the two groups that met the criteria for non-inferiority.

The researchers say the results demonstrate the efficacy of this class of drugs for treating macular oedema secondary to CRVO, but long-term follow up is needed to assess the treatment needs of this group of patients over time.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20202866

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Introduction to Statistics in Pharmaceutical Clinical Trials

    An innovative book which presents statistics in the context of clinical trials conducted during pharmaceutical drug development.

    £38.00
  • Principles of Good Clinical Practice

    A one-stop source for the proper conduct of clinical trials. Essential information on clinical trial design and pharmacovigilance.

    £49.00
  • Quality Assurance of Aseptic Preparation Services: Standards Handbook

    Standards for unlicensed aseptic preparation in the UK, as well as practical information for implementing the standards.

    £46.00
  • FASTtrack: Pharmaceutics - Drug Delivery and Targeting

    Pharmaceutics: Drug Delivery and Targeting systematically reviews important concepts for drug delivery systems and targeting of drugs.

    £25.00
  • Biological Therapeutics

    An introduction to the treatment of disease using biological medicines derived from living plant and animal tissues.

    £33.00
  • Sampson's Textbook of Radiopharmacy

    This well-established textbook provides specialised information on the use of radiopharmaceuticals in the detection and treatment of diseases.

    £81.00

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
grouped logos
www.www.viagraon.com

in detail steroid-pharm.com

steroid-pharm.com

Site powered by